

Watch: A multibillion dollar takeover bid for Australia’s Liontown Resources has been ditched. Meanwhile, CSL is moving to quell concerns weightless drugs like Ozempic will negatively affect its business.


Watch: A multibillion dollar takeover bid for Australia’s Liontown Resources has been ditched. Meanwhile, CSL is moving to quell concerns weightless drugs like Ozempic will negatively affect its business.









Get The New Daily free every morning and evening.
There was an error submitting the form. Please try again.